A CBD maker is among more than a dozen Canadian cannabis companies facing a labeling lawsuit. The lawsuit, filed in Alberta by consumer Lisa Marie Langevin, accuses the companies and their subsidiaries of selling products “with THC or CBD content levels that were drastically different” from what was advertised. Canada allows 15% variance for most […]
Colorado officials who have long since settled how to zone marijuana cultivation to address odor complaints are starting to turn their sights to the hemp industry. Local authorities in Boulder voted this week to limit hemp businesses to three within a 500-foot radius, an attempt to address smell complaints related to the college town’s five […]
Testing of CBD-infused products conducted by the U.S. Food and Drug Administration found that many are mislabeled, containing far less or more CBD than advertised and in some instances THC that wasn’t supposed to be there. Of the 102 products tested this year that were labeled as having CBD, 18 had less than 80% of […]
(Editor’s note: This story is part of a recurring series of commentaries from professionals connected to the hemp industry. Derek Du Chesne is president of Exactus Hemp.) Let’s face it – the hemp industry is dealing with a huge problem, and it’s hurting everyone in the industry, especially growers and processors. The problem in question […]
Multistate marijuana operator Acreage Holdings is getting $100 million to shore up a hemp-focused subsidiary, part of a restructuring announced Thursday with Canadian marijiana giant Canopy Growth Corp. Canopy announced plans tro acquire Acreage last year. The restructuring includes a loan from Canopy so that Acreage’s hemp subsidiary, called Acreage Hempco, can “participate in the […]
“This is common sense legislation that provides physicians, not lawmakers, the ability and discretion to decide what treatment options are best for their patients.”
“Just as doctors are entrusted to make decisions with regard to the supervised use of opioids and other medicines – many of which pose far greater risks to patients than cannabis – the law should provide doctors with similar flexibility when it comes to recommending cannabis therapy to a bona fide patient.”
International cannabis giant Canopy Growth Corp. remains bullish on the U.S. CBD market, even as the company reported an eye-popping net loss of 1.3 billion Canadian dollars ($944 million) last quarter. Canopy told investors Friday that it would revamp its overall strategy after its Canadian recreational marijuana market share saw double-digit declines in the fiscal […]
A marijuana company that has been unwinding some investments in hemp in Canada and Europe changed course Thursday and bought a U.S. company that makes hemp-derived CBD. Canadian producer Aurora Cannabis bought Massachusetts hemp firm Reliva in a $40 million stock deal, checking off a long-stated ambition of the Alberta company’s executives to enter the […]
“The current predicament of a rapidly expanding national marketplace without access to the national banking systems has resulted in an untenable situation.”
